/
Nat Commun
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
- Y.L.D. Ng
- E. Ramberger
- S.R. Bohl
- A. Dolnik
- C. Steinebach
- T. Conrad
- S. Müller
- O. Popp
- M. Kull
- M. Haji
- M. Gütschow
- H. Döhner
- W. Walther
- U. Keller
- L. Bullinger
- P. Mertins
- J. Krönke